CARE · Insider Trading
Carter Bankshares, Inc. Common Stock
Every open-market purchase and sale reported by CARE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Catharine L. Midkiff | Director | Sell | −1,000 | −$31.25K |
| 2026-09-11 | Catharine L. Midkiff | Director | Sell | −1,000 | −$31.25K |
| 2026-08-05 | Gregory W Feldmann | Director | G | −280 | −$9.84K |
| 2026-07-30 | Bradford N. Langs | PRESIDENT, CHIEF STRATEGY OFCR | Sell | −2,500 | −$86.34K |
| 2026-07-30 | Robert M. Bolton | Director | Sell | −1,500 | −$51.90K |
| 2026-07-02 | Tony E Kallsen | SEVP, CHIEF CREDIT OFFICER | A | +5,472 | — |
| 2026-07-02 | Litz H Van Dyke | CHIEF EXECUTIVE OFFICER | A | +12,300 | — |
| 2026-07-02 | Jane Ann Davis | EVP, CHIEF ADMIN. OFFICER | A | +3,604 | — |
| 2026-07-02 | Arthur Loran Adams | EVP, DIRECTOR OF REG RISK MNGT | A | +3,240 | — |
| 2026-07-02 | Matthew M. Speare | SEVP, CHIEF OPERATING OFFICER | A | +5,005 | — |
| 2026-07-02 | Bradford N. Langs | PRESIDENT, CHIEF STRATEGY OFCR | A | +8,649 | — |
| 2026-07-02 | Wendy S. Bell | SENIOR EXECUTIVE VP, CFO | A | +6,428 | — |
| 2026-05-26 | Jane Ann Davis | EVP, CHIEF ADMIN. OFFICER | F | −261 | −$7.03K |
| 2026-05-12 | Bradford N. Langs | PRESIDENT, CHIEF STRATEGY OFCR | Sell | −5,500 | −$145.56K |
| 2026-05-11 | Elizabeth L. Walsh | Director | G | −725 | — |
| 2026-05-07 | Elizabeth L. Walsh | Director | Buy | +4,575 | +$119.86K |
| 2026-05-06 | James W. Haskins | Director | Sell | −1,000 | −$26.04K |
| 2026-04-29 | Jane Ann Davis | EVP, CHIEF ADMIN. OFFICER | A | +1,850 | — |
| 2026-04-29 | Arthur Loran Adams | EVP, DIRECTOR OF REG RISK MNGT | A | +1,650 | — |
| 2026-04-21 | Jane Ann Davis | EVP, CHIEF ADMIN. OFFICER | F | −296 | −$7.18K |
| 2026-03-13 | Litz H Van Dyke | CHIEF EXECUTIVE OFFICER | F | −819 | −$17.18K |
| 2026-03-13 | Bradford N. Langs | PRESIDENT, CHIEF STRATEGY OFCR | F | −638 | −$13.39K |
| 2026-03-13 | Wendy S. Bell | SENIOR EXECUTIVE VP, CFO | F | −435 | −$9.13K |
| 2026-03-13 | Matthew M. Speare | SEVP, CHIEF OPERATING OFFICER | F | −411 | −$8.62K |
| 2026-03-13 | Jane Ann Davis | EVP, CHIEF ADMIN. OFFICER | F | −309 | −$6.48K |
| 2026-02-27 | Litz H Van Dyke | CHIEF EXECUTIVE OFFICER | MIXED | +10,910 | −$25.49K |
| 2026-02-27 | Matthew M. Speare | SEVP, CHIEF OPERATING OFFICER | A | +5,295 | — |
| 2026-02-27 | Bradford N. Langs | PRESIDENT, CHIEF STRATEGY OFCR | MIXED | +7,336 | −$17.19K |
| 2026-02-27 | Arthur Loran Adams | EVP, DIRECTOR OF REG RISK MNGT | A | +1,002 | — |
| 2026-02-27 | Jane Ann Davis | EVP, CHIEF ADMIN. OFFICER | MIXED | +939 | −$6.40K |
| 2026-02-27 | Wendy S. Bell | SENIOR EXECUTIVE VP, CFO | MIXED | +5,251 | −$12.19K |
| 2026-02-27 | Tony E Kallsen | SEVP, CHIEF CREDIT OFFICER | MIXED | +4,007 | −$7.73K |
| 2026-02-02 | Elizabeth L. Walsh | Director | G | −900 | — |
| 2026-01-29 | Elizabeth L. Walsh | Director | G | −835 | — |
| 2026-01-05 | Gregory W Feldmann | Director | A | +1,802 | — |
| 2026-01-05 | Jacob A Lutz III | Director | A | +1,802 | — |
| 2026-01-05 | Catharine L. Midkiff | Director | A | +1,802 | — |
| 2026-01-05 | Elizabeth L. Walsh | Director | A | +1,802 | — |
| 2026-01-05 | Phyllis Q. Karavatakis | Director | A | +1,802 | — |
| 2026-01-05 | Michael R Bird | Director | A | +1,802 | — |
| 2026-01-05 | Robert M. Bolton | Director | A | +1,802 | — |
| 2026-01-05 | James W. Haskins | Director | A | +1,802 | — |
| 2026-01-05 | Kevin S. Bloomfield | Director | A | +1,802 | — |
| 2026-01-05 | Curtis E Stephens | Director | A | +1,802 | — |
| 2025-12-16 | Elizabeth L. Walsh | Director | G | −950 | — |
| 2025-11-03 | Robert M. Bolton | Director | Sell | −1,901 | −$32.75K |
| 2025-09-11 | Matthew M. Speare | SEVP, CHIEF OPERATING OFFICER | Sell | −13,550 | −$268.75K |
| 2025-08-26 | Wendy S. Bell | SENIOR EXECUTIVE VP, CFO | MIXED | −350 | −$4.88K |
| 2025-08-13 | Catharine L. Midkiff | Director | Sell | −2,000 | −$35.52K |
| 2025-07-30 | Catharine L. Midkiff | Director | Sell | −2,000 | −$35.52K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Litz H Van Dyke | CHIEF EXECUTIVE OFFICER | 79,767 | $2.45M |
| Robert M. Bolton | Director | 67,629 | $2.08M |
| James W. Haskins | Director | 64,453 | $1.98M |
| Elizabeth L. Walsh | Director | 62,797 | $1.93M |
| Wendy S. Bell | SENIOR EXECUTIVE VP, CFO | 46,651 | $1.43M |
| Bradford N. Langs | PRESIDENT, CHIEF STRATEGY OFCR | 33,242 | $1.02M |
| Matthew M. Speare | SEVP, CHIEF OPERATING OFFICER | 31,798 | $977.31K |
| Tony E Kallsen | SEVP, CHIEF CREDIT OFFICER | 26,091 | $801.91K |
| Phyllis Q. Karavatakis | Director | 21,695 | $666.80K |
| Jacob A Lutz III | Director | 19,690 | $605.17K |
| Edward Warren Matthews | Director | 18,611 | $572.01K |
| Kevin S. Bloomfield | Director | 18,220 | $559.99K |
| Catharine L. Midkiff | Director | 18,056 | $554.95K |
| Jane Ann Davis | EVP, CHIEF ADMIN. OFFICER | 17,327 | $532.55K |
| Gregory W Feldmann | Director | 16,921 | $520.07K |
| Michael R Bird | Director | 16,576 | $509.46K |
| Arthur Loran Adams | EVP, DIRECTOR OF REG RISK MNGT | 16,302 | $501.04K |
| Curtis E Stephens | Director | 9,032 | $277.60K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CARE quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.